ResearcherInsermNo recent work listed

Philippe Ravaud

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8264-9206; OpenAlex author ID A5050180409. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 2

Papers, trials and grants by year

2022: 2 papers

Papers 2

Availability of Results of Trials Studying Pancreatic Adenocarcinoma over the Past 10 Years. Last author DOI 10.1093/oncolo/oyac156 ↗
Levels of Evidence Supporting United States Guidelines in Pancreatic Adenocarcinoma Treatment. Last author DOI 10.3390/cancers14164062 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Anna Pellat · 2 shared papers, 2022 · strength 0.49
- Paper Availability of Results of Trials Studying Pancreatic Adenocarcinoma over the Past 10 Years. DOI 10.1093/oncolo/oyac156 ↗
- Paper Levels of Evidence Supporting United States Guidelines in Pancreatic Adenocarcinoma Treatment. DOI 10.3390/cancers14164062 ↗
Romain Coriat · 1 shared paper, 2022 · strength 0.22
- Paper Levels of Evidence Supporting United States Guidelines in Pancreatic Adenocarcinoma Treatment. DOI 10.3390/cancers14164062 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.